Why Tyme Stock Got Demolished Today

Shares of Tyme Technologies (NASDAQ: TYME) were down by 36% as of 1:05 p.m. EST today, after the company reported fiscal third-quarter results. Tyme also launched  an at-the-market (ATM) stock offering.

The clinical-stage biotech company said that it presented preliminary supporting data from its TYME-88-Panc pivotal study at a conference last month, which showed the potential role of its SM-88 (racemetyrosine) in advanced pancreatic cancer. 

Image source: Getty Images.

Continue reading

Source Fool.com